Literature DB >> 10025464

Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing.

C J Corral1, A Siddiqui, L Wu, C L Farrell, D Lyons, T A Mustoe.   

Abstract

OBJECTIVES: To test the influence of vascular endothelial growth factor (VEGF) on normal and ischemic wounds in a noncontractive dermal ulcer standardized model in the rabbit ear and to assay the levels of both VEGF and basic fibroblastic growth factor messenger RNA levels in normal and ischemic wounds at different intervals during the healing process. DESIGN AND
INTERVENTIONS: Dermal ulcers were created in the normal and ischemic ears of 20 anesthetized young female New Zealand white rabbits. Either VEGF 121, VEGF 165 (30 microg per wound), or buffered saline solution alone was applied to each wound and covered. Wounds were harvested at day 7 or 10 and evaluated histologically. Twenty-four similar rabbits were wounded in the same manner and their untreated wounds were harvested at 1, 3, 7, and 10 days after wounding. The wounds were analyzed with reverse transcriptase polymerase chain reaction. MAIN OUTCOME MEASURES: Histologic specimens were measured for amount of new epithelium and granulation tissue. Reverse transcriptase polymerase chain reaction was used to determine basic fibroblastic growth factor and VEGF messenger RNA expression.
RESULTS: Both isoforms of VEGF improved granulation tissue formation in both normal and ischemic wounds with a magnitude similar to other vulnerary agents tested in the past. Vascular endothelial growth factor application had no effect on new epithelium formation. In contrast to basic fibroblastic growth factor, VEGF messenger RNA levels were induced 4 fold by ischemia alone and 6 fold by wounding in both ischemic and normal wounds.
CONCLUSION: Vascular endothelial growth factor seems to be more important than basic fibroblastic growth factor during ischemic wound healing. Treatment of ischemic wounds with VEGF improves the deficit in wound healing produced by ischemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025464     DOI: 10.1001/archsurg.134.2.200

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  30 in total

Review 1.  Novel use of platelet-rich plasma to augment curative diabetic foot surgery.

Authors:  Christy L Scimeca; Manish Bharara; Timothy K Fisher; Heather Kimbriel; David G Armstrong
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Tissue Engineering of the Microvasculature.

Authors:  Joe Tien
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

3.  Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions.

Authors:  Candace M Loyd; Doina Diaconu; Wen Fu; Gregory N Adams; Erin Brandt; Dorothy A Knutsen; Julie A Wolfram; Thomas S McCormick; Nicole L Ward
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

4.  Priming with a combination of proangiogenic growth factors improves wound healing in normoglycemic mice.

Authors:  Maximilian Ackermann; Tanja Wolloscheck; Axel Wellmann; Vincent W Li; William W Li; Moritz A Konerding
Journal:  Int J Mol Med       Date:  2011-03-03       Impact factor: 4.101

5.  Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164.

Authors:  Veronica Sacchi; Rainer Mittermayr; Joachim Hartinger; Mikaël M Martino; Kristen M Lorentz; Susanne Wolbank; Anna Hofmann; Remo A Largo; Jeffrey S Marschall; Elena Groppa; Roberto Gianni-Barrera; Martin Ehrbar; Jeffrey A Hubbell; Heinz Redl; Andrea Banfi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

6.  Standardization for mass production of allogeneic cultured dermal substitute by measuring the amount of VEGF, bFGF, HGF, TGF-beta, and IL-8.

Authors:  Akiko Hashimoto; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

7.  Expression of vascular endothelial growth factor and angiogenesis in patellar tendon grafts in the early phase after anterior cruciate ligament reconstruction.

Authors:  T Yoshikawa; H Tohyama; H Enomoto; H Matsumoto; Y Toyama; K Yasuda
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-03-14       Impact factor: 4.342

8.  VEGF gene therapy augments localized angiogenesis and promotes anastomotic wound healing: a pilot study in a clinically relevant animal model.

Authors:  C Kristian Enestvedt; Luke Hosack; Shelley R Winn; Brian S Diggs; Barry Uchida; Robert W O'Rourke; Blair A Jobe
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

Review 9.  Wound healing in radiated skin: pathophysiology and treatment options.

Authors:  Andrea Olascoaga; Diana Vilar-Compte; Adela Poitevin-Chacón; Jose Contreras-Ruiz
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

10.  [Influence of local application of basic fibroblast growth factor on resistance to local infection after standardized closed soft tissue trauma. An experimental study in rats].

Authors:  T Kälicke; O Sprutacz; U Schlegel; F Kutscha-Lissberg; M Köller; G Printzen; G Muhr; S Arens
Journal:  Unfallchirurg       Date:  2004-03       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.